Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An anaplastic astrocytoma lacking mutations in IDH1 or IDH2 genes.
Biomarker and diagnostic research for IDH-wildtype anaplastic astrocytoma has been reported in the published literature.
No clinical trials have been registered for IDH-wildtype anaplastic astrocytoma.
200 publications have been identified in PubMed for IDH-wildtype anaplastic astrocytoma. Kisho has analyzed 86 by research type. Research spans Basic Science / Preclinical (36%), Diagnostic / Biomarker (21%), and Review / Meta-Analysis (15%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 31 | 36% |
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 12:39 AM UTC
Common questions about IDH-wildtype anaplastic astrocytoma
Testing and diagnosis research |
18 |
21% |
Research summaries | 13 | 15% |
Disease patterns and progression | 11 | 13% |
Clinical study results | 6 | 7% |
Patient case studies | 5 | 6% |
New treatment approaches | 2 | 2% |
Savani MR (2026). [PMID: 41137658](https://pubmed.ncbi.nlm.nih.gov/41137658/). *Neuro Oncol*. [Basic Science / Preclinical]
McDonald MF (2026). [PMID: 41962162](https://pubmed.ncbi.nlm.nih.gov/41962162/). *J Neurosurg*. [Basic Science / Preclinical]
Kegoya Y (2026). [PMID: 41742683](https://pubmed.ncbi.nlm.nih.gov/41742683/). *Cancer Sci*. [Review / Meta-Analysis]
Radu R (2026). [PMID: 41596752](https://pubmed.ncbi.nlm.nih.gov/41596752/). *Int J Mol Sci*. [Diagnostic / Biomarker]
Brat DJ (2026). [PMID: 42152226](https://pubmed.ncbi.nlm.nih.gov/42152226/). *Neuro Oncol*. [Diagnostic / Biomarker]
Seferbekova Z (2026). [PMID: 41783996](https://pubmed.ncbi.nlm.nih.gov/41783996/). *Neuro Oncol*. [Basic Science / Preclinical]
Wu F (2026). [PMID: 41485080](https://pubmed.ncbi.nlm.nih.gov/41485080/). *Neuro Oncol*. [Basic Science / Preclinical]
Zeyen T (2026). [PMID: 41233976](https://pubmed.ncbi.nlm.nih.gov/41233976/). *Neuro Oncol*. [Diagnostic / Biomarker]
Ribeiro AB (2026). [PMID: 41642473](https://pubmed.ncbi.nlm.nih.gov/41642473/). *Invest New Drugs*. [Clinical Trial Publication]
Moon HH (2025). [PMID: 40326876](https://pubmed.ncbi.nlm.nih.gov/40326876/). *Radiology*. [Epidemiology / Natural History]